ZJYL Jin Medical International Ltd. Annual reports only
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1837821 · Fiscal year ends 09/30
Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-12.0%
TTM net income YoY-67.6%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR2.5%
Net income 3-yr CAGR-23.9%
Margins
Gross margin29.2%
Operating margin2.9%
Net margin5.8%
FCF margin-18.0%
EBITDA margin4.1%
Returns
ROE4.1%
ROA2.4%
ROIC (approx.)2.5%
Asset turnover0.42x
Leverage & solvency
Liabilities / assets44.6%
Debt / equity0.00x
Current ratio1.86x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.44x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue32.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $20.69M | $23.50M |
| Cost of revenue | $14.64M | $14.00M |
| Gross profit | $6.04M | $9.50M |
| R&D expense | $1.56M | $1.50M |
| SG&A expense | $2.53M | $3.26M |
| Operating income | $608,182 | $3.64M |
| Pretax income | $1.60M | $4.18M |
| Income tax | $214,572 | $763,879 |
| Net income | $1.19M | $3.68M |
| EBITDA | $851,585 | $3.88M |
| EPS (basic) | 0.01 | 0.02 |
| EPS (diluted) | 0.01 | 0.02 |
| Weighted avg. shares (diluted) | 156.55M | 156.47M |
| Balance sheet | ||
| Cash & equivalents | $7.46M | $8.14M |
| Short-term investments | $22.17M | $18.62M |
| Receivables | $5.81M | $5.91M |
| Inventory | $4.92M | $5.17M |
| Current assets | $44.14M | $42.82M |
| PP&E, net | $7.90M | $1.46M |
| Intangibles | $1.10M | $1.15M |
| Total assets | $53.37M | $45.80M |
| Current liabilities | $23.80M | $17.15M |
| Short-term debt | $18.84M | $11.32M |
| Total liabilities | $23.80M | $17.25M |
| Shareholders' equity | $29.64M | $28.82M |
| Shares outstanding | 156.55M | 155.95M |
| Cash flow statement | ||
| Operating cash flow | $2.90M | -$1.21M |
| Capital expenditure | $6.63M | $144,949 |
| Free cash flow | -$3.73M | -$1.35M |
| Investing cash flow | -$10.79M | -$9.51M |
| Financing cash flow | $7.35M | $11.65M |
| Depreciation & amortization | $243,403 | $237,823 |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.